A case of tuberculosis pleuritis developing contralateral pleural effusion during anti-tuberculosis chemotherapy,falling into chronic respiratory failure

The patient was a 74 year-old male presenting right pleural effusion with mild fever. His temperature was 37.0 degrees C. Culture of a pleural biopsy specimen revealed Mycobacterium tuberculosis, although culture of sputum and pleural effusion were negative. Therapy was begun with 300 mg of isoniazid (INH) per day, 600 mg of rifampicin (RFP) per day, and 1200 mg of pyrazinamide (PZA) per day. His temperature improved temporarily. One week after beginning of the therapy he had a fever over 38.0 degrees C. On the 17th day after starting chemotherapy, a chest radiological examination showed left pleural effusion in which numerous lymphocytes were found but Mycobacterium tuberculosis was negative. We assumed that the left pleural effusion was due to a paradoxical reaction to the anti-tuberculosis chemotherapy. After 3 days' discontinuation, the same regimen was resumed with an addition of prednisolone, but bilateral pleural effusion remained and the case finally fell into chronic respiratory failure.     

Contralateral pleural effusion during chemotherapy for tuberculous pleurisy

A 46-year-old woman developed a right pleural effusion 8 weeks after standard chemotherapy for tuberculous pleurisy on the left side had been started. Pleural biospy demonstrated caseous granulomatous changes. The patient improved following continuation of the same treatment.     

A case of tuberculous peritonitis developed during chemotherapy for tuberculous pleurisy as paradoxical response

After the start of anti-tuberculous treatment, paradoxical worsening of tuberculous lesions has been described. However, abdominal tuberculosis as paradoxical response is relatively rare. This report describes the 26-year-old female who suffered from peritoneal tuberculosis while treating tuberculous pleurisy with anti-tuberculous medications. It was considered as paradoxical response, rather than treatment failure or else. She was successfully managed with continuing initial anti-tuberculous medications. When a patient on anti-tuberculous medications is presented with abdominal symptoms, the possibility of paradoxical response should be considered to avoid unnecessary tests and treatments, which may result in more suffering of the patient. Herein, we report a case of peritoneal tuberculosis as paradoxical response while treating tuberculous pleurisy.     

A case having chyliform pleural effusion caused by former tuberculous pleurisy

A 49-year-old male who had been treated for pulmonary tuberculosis and tuberculous pleurisy in 2007 was referred to our hospital with the complaint of dyspnea on exertion in Nov. 2009. Chest X-ray showed increased pleural effusion compared with that remaining after the previous treatment of pleurisy in 2008. A chest CT revealed that fluid collection was surrounded by thickened pleura. Thoracocentesis was performed, and yellow milky liquid was obtained. The pleural effusion contained few cells. The triglyceride concentration was 83 mg/dl, and the cholesterol level was very high at 628 mg/dl. Based on these findings we diagnosed this case as chyliform pleural effusion. Both smear of acid-fast bacilli and PCR-TB test of the pleural effusion were positive, but culture was negative for mycobacterium, suggesting that this chyliform pleural effusion was produced by the former episode of tuberculous pleurisy, not by the recent reactivation of tuberculous pleurisy. The ADA concentration in the pleural effusion was high at 91.7 IU/l. No increase in the amount of pleural effusion was observed after thoracocentesis without any anti-tuberculosis therapy.     

A case of tuberculous pleurisy with a rapid decrease in pleural effusion]

We report a rare case of tuberculous pleurisy with a rapid decrease in pleural effusion by levofloxacin. A 73-year-old woman admitted due to dyspnea on exertion of one month duration. She had aortitis syndrome which had been treated with oral prednisolone for 6 months. Chest roentgenogram showed left pleural effusion, which was exudative with lymphocyte predominance and an increased level of adenosine deaminase. One-week administration of levofloxacin remarkably decreased effusion. as demonstrated on chest roentgenogram 2 weeks after treatment. Since Mycobacterium tuberculosis was isolated in culture from bronchial lavage fluid and sputum, we prescribed antituberculous therapy with isoniazid, rifampicin and ethambutol. resulting in complete resolution.     

A case of tuberculous pyometrium concurrent with tuberculous pleurisy

An 84-year-old woman began to have low fever below 38 degrees C with slight lassitude from June 19, 2002. Despite oral administration of Clarithromycin for 3 days, the fever did not subside and the lassitude increased, so she was admitted to our department. While inflammatory findings were noticed, the cause was not identified by blood and imaging examinations (thoracoabdominal CT, etc.). Although her tuberculin reaction was positive, symptoms indicative of pulmonary tuberculosis were absent. Administration of Cefotiam and Imipenem Cilastatin sodium was ineffective. Pyometra was diagnosed. After drainage, the uterine cavity was washed every day. On the basis of culture of fluid retained a few colonies of Gram-negative bacteria were isolated, but were not identified, Cefpirome was administered, whereupon the fever subsided gradually, but mild inflammatory findings remained. Even after discharge on July 24, the retention increased, so drainage and washing were done repeatedly. However, mild inflammatory findings persisted. She began to have a fever from September 17 and was readmitted. After admission, administration of Flomoxef sodium was started, but no improvement was seen. A small amount of hydrothorax appeared on the left. Thoracocentesis yielded a bloody, slightly turbid exudative. Acid-fast staining and Mycobacterium tuberculosis specific PCR of pleural effusion were negative, but adenosindeaminase was 87.4 U/l. Therefore, a diagnosis of tuberculous pleurisy was made. DNA/PCR of tubercle bacilli in the fluid retained in the uterus was positive, and re-retention was prevented by administration of anti-tuberculosis drugs. These findings suggest a strong possibility of tubercle bacillus having been the causative bacteria. Particularly in the case of the elderly, it appears important that pyometra be included in differential diagnosis as the cause of fever even without gynecological symptoms and that tubercle bacillus be considered the causative bacterium.     

Case of pubic tuberculous osteomyelitis and pericarditis during anti-tuberculosis chemotherapy

56 year-old man was referred to the department of orthopedics in our hospital for further investigation on right inguinal pain. The patient was initially diagnosed as bacterial myelitis in right pubic bone and was treated with antibiotics. Since his symptom did not improve, the curettage was performed. Histological examination of the pubic bone obtained during the operation showed epithelioid cell granulomas with caseous necrosis, supporting the diagnosis of tuberculous osteomyelitis. Chest X-ray film revealed small nodular lesions in both upper lung fields. Sputum was positive for acid-fast bacilli and Amplified Mycobacterium Tuberculosis Direct Test (TB-MTD) was positive. The diagnosis of pubic tuberculous osteitis and pulmonary tuberculosis was confirmed. Specimens from the pubic bone and sputum were both culture positive for Mycobacterium tuberculosis, and bacilli were sensitive to anti-tuberculosis drugs. The antituberculosis chemotherapy was started with INH, RFP, SM and PZA. Symptoms had gradually improved, however 3 months after starting treatment, high fever developed and chest X-ray revealed heart enlargement and bilateral pleural effusion. Pericardial effusion showed exudative nature with lymphocyte predominancy and high level of ADA, 98.4 U/l. Pleural effusion was transudate. TB-MTD and culture were negative both in pericardial and pleural effusion. Paradoxical reaction was thought to be the cause of pericarditis. TB chemotherapy was continued and pericardial drainage was performed. One month later, fever improved, and pleural effusion and pericardial effusion disappeared. Transient elevated transaminase was observed, and was thought to be the side effect of anti TB drugs. All symptoms gradually improved, and he was discharged after 6 months TB chemotherapy.     

A case of tuberculous pericardial effusion

We report a case of an 80-year-old caucasian female in the UK who presented with weight loss and was found to have a pericardial effusion. There was neither previous exposure to tuberculosis nor any suggestion of immunosuppression. Repeated analysis of pericardial fluid established a tuberculous origin. Search of medical literature did not reveal any similar cases in the elderly in the UK.     

胸腔镜冷冻治疗纤维黏连为主型结核性胸腔积液的临床观察

目的探讨经胸腔镜微创冷冻治疗结核性胸腔积液形成纤维黏连及壁层胸膜结核结节的临床疗效。方法对38例结核性胸腔积液形成纤维黏连的患者通过内科胸腔镜微创检查并对纤维黏连带采用冷冻探针清除,并对壁层胸膜结核结节进行冻融治疗。结果患者胸腔内见大量纤维黏连形成,采用冷冻探针进行冻切后可清除胸腔内病变,壁层胸膜结核结节通过冻融治疗后迅速坏死。经治疗后患者症状改善,胸腔积液吸收明显。显效:12例(31.6%);有效24例(63.2%),无效2例(5.3%),总有效率94.7%。结论内科胸腔镜能及时发现胸腔纤维黏连,并可以在直视下对病变进行清除,冷冻治疗是内镜介入治疗胸膜病变的有效方法,且安全。     

胸水抗PPD-IgG在结核性胸膜炎中的临床意义

目的：评价胸水抗PPD－IgG检测对结核性胸膜炎的临床意义。方法：采用斑点免疫金渗滤技术（金标法）检测70例结核性胸膜炎患血清及胸水抗PPD－IgG，同时作PPD皮试，并随机选择24例非结核性胸腔积液作为对照组。结果：结核组血清、胸水中抗PPD－IgG阳性中分别为60．00％和52．86％，显高于对照组血清及胸水中抗PPD－IgG阳性中（8．33％和16．67％），P＜0．01；血清抗PPD－IgG敏感性为60．00％，特异性91．67％，胸水抗PPD－IgG敏感性52．86％，特异性83．33％，同时测胸水、血清抗PPD-IgG敏感性68．57％，特异性91．67％。结核组PPD总阳性率73．81％。结论：同时测定血清、胸水抗PPD－IgG联合PPD皮试，将会提高结核性胸膜炎诊断的敏感性和诊断率。     

蝮蛇抗栓酶对结核性渗出性胸膜炎的治疗作用

对７７例结核性渗出性胸膜炎病人在化疗的同时加用蝮蛇抗栓酶静脉滴注及胸腔内注入，与应用肾上腺皮质激素的４６例对比。结果：蝮蛇抗栓酶在促进渗液吸收、预防胸膜粘连方面，优于激素，而对中毒症状的缓解则激素优于蝮蛇抗栓酶。除１例出现皮疹外，未见其他不良反应。     

Case of tuberculous pleurisy with eosinophilic pleural effusion and hematological eosinophilia

A 30-year-old man suffered from a chest-pain on his left side and was also having a low-grade fever though he actually neglected these symptoms for a while. Later, he was referred to our hospital due to the detection of chest abnormal shadows through the mass examination of chest X-ray taken on 18th October, 2005. His chest X-ray showed bilateral pleural effusion and it was confirmed that the right pleural effusion was encapsulated by his chest CT. The patient's hematological examination performed during his initial visit, showed an increased level of WBC with blood eosinophilia. He also had a puncture of pleural effusion at the time of admission to the center. Moreover, pleural effusion on both sides was exudative and elevations of ADA and eosinophil count as well were traced. In the patient's right pleural effusion, mycobacterium tuberculosis direct (MTD) test was positive. As there were no findings suggesting collagen disease, malignancy, parasite infection, and other complications, he was diagnosed as tuberculous pleurisy with eosinophilic pleural effusion and blood eosinophilia. He was treated with four antitubercular agents, namely, INH, RFP, EB and PZA. As the result, his pleural effusion and blood eosinophil counts were decreased along with an improvement in inflammatory reaction. The most common conditions associated with eosinophilic pleural effusion are described as malignancy, collagen disease, paragonimiasis, drug induced pleurisy, asbestosis, pneumothorax, and trauma, while there are only a few reports about such eosinophilic pleural effusion caused by tuberculous pleurisy. In this case, he also showed blood eosinophilia. Based on these findings, we finally came to the conclusion that the case is a very rare and significantly unique case of eosinophilic pleurisy with blood eosinophilia.     

肝硬化合并结核性胸膜炎1例报告

<正>1病历资料男性患者,25岁,以腹胀1个月,发热半个月,加重2 d为主诉,于2011年10月14日至本科住院治疗。患者10余年前体检发现HBsAg阳性,自述当时肝功能正常,未予重视及系统诊治。1个月前自觉腹胀,体检发现少量腹水,仍未重视及进一步诊治,近半个月出现发热,最高体温38.7℃,无恶寒,无鼻塞流涕,无咳嗽咳痰,在当地诊所予对症治疗后体温下降,未行进一步诊治。2 d前自觉腹胀加重,遂至本院肝病门诊就     

A clinical study of tuberculous pleurisy

A clinical study of 38 patients (28 men and 10 women) with tuberculous pleurisy was conducted. The age of these patients ranged from 19 to 92 years, with an average age of 48.9 years. In 30 patients, the chief complaint was fever, and other common complaints included chest pain, dyspnea, and coughing. Bacillus tuberculosis was found in the pleural fluid of 7.9% of the patients. Tuberculous pleurisy was diagnosed histologically, based on pleural biopsy, in 23.7% of the patients. The diagnosis rate of pleural biopsy was 47.4%. There were no significant differences in results of blood and pleural fluid tests between idiopathic pleurisy and concomitant pleurisy, but the tuberculin skin test was positive in only 50% of the patients with concomitant pleurisy. The tendency was that the longer the time period between symptom onset and first examination, the greater the pleural fluid retention. The diagnosis rate of pleural biopsy was influenced by the severity of pleural fluid retention. A thoracic cavity drain was inserted for continuous drainage in 15 patients, and every patient underwent INH + RFP-based chemotherapy. Tuberculous pleurisy is an important disease among patients with pleural fluid retention, thus clinicians need to know how to treat this disease.     

非活动性结核性胸膜炎与活动性结核性胸膜炎的CT扫描影像特征分析

目的: 探讨非活动性结核性胸膜炎与活动性结核性胸膜炎CT扫描影像表现。方法: 对2012年6月1日至2021年3月30日在首都医科大学附属北京胸科医院就诊的单纯非活动性结核性胸膜炎患者68例和同期活动性结核性胸膜炎44例的CT扫描影像表现进行比较。结果: (1) 68例非活动性结核性胸膜炎患者 CT扫描影像表现中胸膜粘连62例(91.2%),胸膜有钙化者28例(41.2%),叶间裂受累22例(32.4%),胸腔积液12例(17.6%),包裹性胸腔积液8例(11.8%)。(2)44例活动性结核性胸膜炎患者CT扫描影像表现中胸膜粘连30例(68.2%),未见胸膜钙化,叶间裂受累32例(72.7%),胸腔积液43例(97.7%),包裹性胸腔积液26例(59.1%)。(3)非活动性与活动性结核性胸膜炎CT扫描影像比较:胸膜粘连、胸膜钙化发生率高,差异均有统计学意义(χ²=9.630,P=0.002;χ²=23.737,P=0.000);叶间裂受累、胸腔积液、包裹性胸腔积液的发生率低,差异均有统计学意义(χ²=12.692,P=0.000;χ²=68.548,P=0.000;χ²=28.301,P=0.000)。结论: 非活动性结核性胸膜炎的CT扫描影像与活动性结核性胸膜炎比较胸膜粘连、胸膜钙化的发生率高,胸腔积液、包裹性胸腔积液、叶间裂受累的发生率低。识别非活动性和活动性结核性胸膜炎的CT扫描影像特点,对患者临床治疗有指导意义。     

结核性胸膜炎胸液中纤维蛋白原含量对胸膜肥厚及粘连形成的影响

目的　探讨结核性渗出性胸膜炎胸腔积液纤维蛋白原含量与胸膜肥厚、粘连的关系。方法117例初治结核性渗出性胸膜炎患者按胸腔积液纤维蛋白原含量从低到高分为A、B、C 3组 ,治疗过程中和治疗后测定胸膜厚度 ,评估胸膜粘连发生率。结果 治疗过程中胸膜厚度 :A组与B组比较 (t=2 .5 7,P<0.05 )有显著性差异 ,A组与C组比较 (t=7.15 ,P<0 .0 1)有显著差异性 ,B组与C组比较 (t=2.46 ,P<0 .0 5 )有显著性差异 ;胸膜粘连发生率 :A组与B组比较 (χ²=3.5 1,P>0.05 )无显著性差异 ,A组与C组比较 (χ²=9.87,P<0 .01)有显著性差异 ,B组与C组比较 (χ²=4 .5 1,P<0 .0 5 )有显著性差异。治疗结束时胸膜厚度 :A组与B组比较 (t=1.4 5 ,P>0 .0 5 )无显著性差异 ,A组与C组比较 (t=3.4 6 ,P<0.01)有显著性差异 ,B组与C组比较 (t=2 .89,P<0 .0 1)有显著性差异 ;胸膜粘连发生率 :A组与B组比较 (χ²=0 .10 ,P>0 .0 5 )无显著性差异 ,A组与C组比较 (χ²=4 .36 ,P<0.05)有显著性差异 ,B组与C组比较 (χ²=7.4 9,P<0 .0 1)有显著性差异。结论 胸液纤维蛋白原含量可影响胸膜肥厚度与胸膜粘连发生率。